Alison N Kurimchak
7PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 31, 2025
Characterization of MEK1/2 Degraders Uncovers a Kinase-Independent Role for MEK1/2 in the Stabilization and Maturation of CRAF.Jason S Wasserman, Alison M Kurimchak, Carlos Herrera-Montávez
|Jul 09, 2024
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs.Jason S Wasserman, Bulat Faezov, Kishan R Patel
|Mar 11, 2024
KRAS mutation-selective requirement for ACSS2 in colorectal adenoma formation.Konstantin Budyagan, Alexa C Cannon, Adam Chatoff
|Jan 19, 2024
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.Alexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez
|Mar 22, 2023
FAM122A ensures cell cycle interphase progression and checkpoint control as a SLiM-dependent substrate-competitive inhibitor to the B55⍺/PP2A phosphatase.Jason S Wasserman, Bulat Faezov, Kishan R Patel
|Aug 30, 2022
The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells.Alison M Kurimchak, Carlos Herrera-Montávez, Sara Montserrat-Sangrà
Pageof 2
Frequent Collaborators
4 joint publications
James S Duncan
3 joint publications
Jonathan Chernoff
3 joint publications
Jason S Wasserman
2 joint publications
Roland L Dunbrack
2 joint publications
Arminja N Kettenbach
2 joint publications
Xavier Graña
2 joint publications
Qifang Xu
1 joint publications
Vikas Kumar
1 joint publications
Shane O'Brien
1 joint publications
Daniela Araiza-Olivera
